FDA greenlights Lilly obesity pill as Novo heats up race
US regulators have approved Eli Lillyβs new obesity pill, escalating the already fierce GLP-1 weight-loss race where Novo Nordisk has been gaining ground. The s...
Latest trending topics in Health
US regulators have approved Eli Lillyβs new obesity pill, escalating the already fierce GLP-1 weight-loss race where Novo Nordisk has been gaining ground. The s...
Match Day is the annual turning point when medical students learn where theyβll train for residency, and it shapes careers, finances, and wellbeing. Experts are...
Reports suggest discontinuing GLP-1 medications (like semaglutide/tirzepatide) often leads to meaningful weight regain and may worsen cardiometabolic risk facto...
Costco is beginning to offer members access to Sesame fertility care, signaling how fertility support is moving from niche employer perks to mainstream consumer...